Please provide your email address to receive an email when new articles are posted on . The overall rate of hospital-onset bacteremia and fungemia that was likely secondary to HOUTI was 3.7%.

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

Please provide your email address to receive an email when new articles are posted on . Expanding beyond UTI vs. not UTI diagnostic guidelines may improve treatment and antimicrobial stewardship.

Urinary tract infections are the most common type of healthcare-associated infection in the U.S. For hospitals looking to combat UTIs, a recent study published in the American Journal of Infection ...

Avoiding the unnecessary use of indwelling catheters and promptly removing catheters that are no longer needed are the first steps in preventing catheter-associated urinary tract infections in acute ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

In the INSPIRE UTI trial, use of the computerized provider order entry (CPOE) stewardship bundle -- including education, feedback, and real-time and risk-based CPOE prompts -- resulted in a 17.4% ...

Washington University School of Medicine in St. Louis has become the first to treat a patient with recurrent urinary tract infections with RBX2660, a microbiota-based drug candidate developed by ...

Recurrent Urinary Tract Infections (UTIs) can be prevented for up to nine years in more than half of people given an oral spray-based vaccine and is a potential alternative to antibiotic treatments, ...